{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:51:14Z","timestamp":1785855074969,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer progression is increasingly recognized as a dynamic process shaped by reciprocal communication between malignant cells and the tumor microenvironment (TME). Among immune-cell populations, tumor-associated macrophages (TAMs) are major regulators of immune suppression, metabolic adaptation, angiogenesis, and therapeutic resistance. Emerging evidence indicates that extracellular vesicle (EV)-mediated transfer of long non-coding RNAs (lncRNAs) constitutes an important mechanism underlying tumor\u2013immune communication in breast cancer. In this review, we summarize mechanistically characterized studies examining how exosomal lncRNAs regulate bidirectional signaling between breast cancer cells and macrophages and contribute to tumor progression, immune remodeling, and resistance-associated phenotypes. Tumor-derived exosomal lncRNAs modulate macrophage signaling through pathways associated with signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta (TGF-\u03b2), Hippo\/Yes-associated protein (YAP), hypoxia-responsive signaling, and autophagy-related remodeling, thereby promoting immunoregulatory and tumor-supportive macrophage phenotypes. Conversely, macrophage-derived exosomal lncRNAs, including hypoxia-inducible factor-1 alpha (HIF-1\u03b1)-stabilizing long non-coding RNA (HISLA), reinforce glycolytic adaptation, epithelial\u2013mesenchymal transition, epigenetic remodeling, metastatic plasticity, and resistance to therapy in recipient tumor cells. Exosomal lncRNA signaling additionally influences \u03b3\u03b4 T cells, endothelial cells, and stromal compartments, supporting broader multicellular regulation within the TME. Collectively, current evidence supports exosomal lncRNAs as biologically important mediators of tumor\u2013immune adaptation in breast cancer. We further discuss the translational potential of circulating exosomal lncRNAs as minimally invasive biomarkers and evaluate therapeutic strategies targeting EV biogenesis, vesicle trafficking, and oncogenic lncRNA cargo molecules. Finally, we highlight current limitations involving EV heterogeneity, lncRNA stoichiometry, and incomplete in vivo validation that remain critical barriers to clinical translation.<\/jats:p>","DOI":"10.1007\/s10238-026-02199-z","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T03:22:33Z","timestamp":1780197753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4997-5143","authenticated-orcid":false,"given":"Mahsa","family":"Javadian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-6251","authenticated-orcid":false,"given":"Tahereh","family":"zeinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9669-7397","authenticated-orcid":false,"given":"Morteza","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1357-4704","authenticated-orcid":false,"given":"Zahra","family":"Mehrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8638-1076","authenticated-orcid":false,"given":"Mahsa","family":"Boogari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6056-9803","authenticated-orcid":false,"given":"Faezeh","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-3237","authenticated-orcid":false,"given":"Saeed","family":"Samaeinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-9343","authenticated-orcid":false,"given":"Zahra","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1234-9562","authenticated-orcid":false,"given":"Hossein","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0172-8536","authenticated-orcid":false,"given":"Rozhina","family":"Sabzehban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0193-0035","authenticated-orcid":false,"given":"Khadijeh","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8585-5175","authenticated-orcid":false,"given":"Kiana","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6017-887X","authenticated-orcid":false,"given":"Zohreh","family":"Khaksarhaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-1922","authenticated-orcid":false,"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-7238","authenticated-orcid":false,"given":"Ramazan","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"publisher","first-page":"1302587","DOI":"10.3389\/fimmu.2024.1302587","volume":"15","author":"T Akinsipe","year":"2024","unstructured":"Akinsipe T, Mohamedelhassan R, Akinpelu A, Pondugula SR, Mistriotis P, Avila LA, et al. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics. Front Immunol. 2024;15:1302587.","journal-title":"Front Immunol"},{"key":"2199_CR2","first-page":"33008","volume":"63","author":"MO Fj\u00f8rtoft","year":"2024","unstructured":"Fj\u00f8rtoft MO, Huse K, Rye IH. The tumor immune microenvironment in breast cancer progression. Acta Oncol (Madr). 2024;63:33008.","journal-title":"Acta Oncol (Madr)"},{"issue":"19","key":"2199_CR3","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/cancers13194798","volume":"13","author":"LEL Terceiro","year":"2021","unstructured":"Terceiro LEL, Edechi CA, Ikeogu NM, Nickel BE, Hombach-Klonisch S, Sharif T, et al. The breast tumor microenvironment: A key player in metastatic spread. Cancers (Basel). 2021;13(19):4798.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2199_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"key":"2199_CR5","doi-asserted-by":"publisher","first-page":"1295257","DOI":"10.3389\/fimmu.2023.1295257","volume":"14","author":"U Basak","year":"2023","unstructured":"Basak U, Sarkar T, Mukherjee S, Chakraborty S, Dutta A, Dutta S, et al. Tumor-associated macrophages: an effective player of the tumor microenvironment. Front Immunol. 2023;14:1295257.","journal-title":"Front Immunol"},{"key":"2199_CR6","doi-asserted-by":"publisher","first-page":"1560393","DOI":"10.3389\/fimmu.2025.1560393","volume":"16","author":"H Jin","year":"2025","unstructured":"Jin H, Meng X, Feng J. Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy. Front Immunol. 2025;16:1560393.","journal-title":"Front Immunol"},{"key":"2199_CR7","doi-asserted-by":"publisher","first-page":"643771","DOI":"10.3389\/fimmu.2021.643771","volume":"12","author":"AK Mehta","year":"2021","unstructured":"Mehta AK, Kadel S, Townsend MG, Oliwa M, Guerriero JL. Macrophage biology and mechanisms of immune suppression in breast cancer. Front Immunol. 2021;12:643771.","journal-title":"Front Immunol"},{"issue":"1","key":"2199_CR8","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell vesicles. 2018;7(1):1535750.","journal-title":"J Extracell vesicles"},{"key":"2199_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3389\/fimmu.2018.00871","volume":"9","author":"S Ham","year":"2018","unstructured":"Ham S, Lima LG, Chai EPZ, Muller A, Lobb RJ, Krumeich S, et al. Breast cancer-derived exosomes alter macrophage polarization via gp130\/STAT3 signaling. Front Immunol. 2018;9:871.","journal-title":"Front Immunol"},{"issue":"1","key":"2199_CR10","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4(1):2980.","journal-title":"Nat Commun"},{"key":"2199_CR11","doi-asserted-by":"crossref","unstructured":"Ashekyan O, Abdallah S, Shoukari A, Al, Chamandi G, Choubassy H, Itani ARS et al. Spotlight on exosomal non-coding RNAs in breast cancer: an in silico analysis to identify potential lncRNA\/file:\/\/\/C:\/Users\/asus\/Downloads\/scholar (60).riscircRNA-miRNA-target axis. Int J Mol Sci. 2022;23(15):8351.","DOI":"10.3390\/ijms23158351"},{"issue":"1","key":"2199_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9\u201317.","journal-title":"Nat Cell Biol"},{"issue":"6478","key":"2199_CR13","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Sci (80-). 2020;367(6478):eaau6977.","journal-title":"Sci (80-)"},{"issue":"16","key":"2199_CR14","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.3390\/cancers13164233","volume":"13","author":"JJ Li","year":"2021","unstructured":"Li JJ, Tsang JY, Tse GM. Tumor microenvironment in breast cancer\u2014updates on therapeutic implications and pathologic assessment. Cancers (Basel). 2021;13(16):4233.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2199_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12032-022-01670-7","volume":"39","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wu J, Wang L, Zhao H, He J. Tumor-associated macrophages of the M1\/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway. Med Oncol. 2022;39(7):83.","journal-title":"Med Oncol"},{"issue":"652","key":"2199_CR16","doi-asserted-by":"publisher","first-page":"eaax4585","DOI":"10.1126\/scisignal.aax4585","volume":"13","author":"V G\u00f3mez","year":"2020","unstructured":"G\u00f3mez V, Eykyn TR, Mustapha R, Flores-Borja F, Male V, Barber PR, et al. Breast cancer\u2013associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Sci Signal. 2020;13(652):eaax4585.","journal-title":"Sci Signal"},{"key":"2199_CR17","doi-asserted-by":"publisher","first-page":"664904","DOI":"10.3389\/fonc.2021.664904","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Li P, Zhang Z, Wu M. Insights into exosomal non-coding RNAs sorting mechanism and clinical application. Front Oncol. 2021;11:664904.","journal-title":"Front Oncol"},{"issue":"1","key":"2199_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ncrna8010016","volume":"8","author":"A Benedetti","year":"2022","unstructured":"Benedetti A, Turco C, Fontemaggi G, Fazi F. Non-coding RNAs in the crosstalk between breast cancer cells and tumor-associated macrophages. Non-coding RNA. 2022;8(1):16.","journal-title":"Non-coding RNA"},{"issue":"4","key":"2199_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","volume":"21","author":"F Chen","year":"2019","unstructured":"Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, et al. Extracellular vesicle-packaged HIF-1\u03b1-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21(4):498\u2013510.","journal-title":"Nat Cell Biol"},{"key":"2199_CR20","doi-asserted-by":"publisher","first-page":"620773","DOI":"10.3389\/fonc.2021.620773","volume":"11","author":"C Deligne","year":"2021","unstructured":"Deligne C, Midwood KS. Macrophages and extracellular matrix in breast cancer: partners in crime or protective allies? Front Oncol. 2021;11:620773.","journal-title":"Front Oncol"},{"issue":"5","key":"2199_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","volume":"54","author":"E Danenberg","year":"2022","unstructured":"Danenberg E, Bardwell H, Zanotelli VRT, Provenzano E, Chin SF, Rueda OM, et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat Genet. 2022;54(5):660\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"2199_CR22","first-page":"14","volume":"4","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P, Silvestri R, Gemignani F. The breast cancer tumor microenvironment and precision medicine: Immunogenicity and conditions favoring response to immunotherapy. J Natl Cancer Cent. 2024;4(1):14\u201324.","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"2199_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/1759-7714.14268","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Cao J, Zu X. Tumor-associated macrophages: An important player in breast cancer progression. Thorac cancer. 2022;13(3):269\u201376.","journal-title":"Thorac cancer"},{"issue":"6","key":"2199_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2199_CR25","doi-asserted-by":"publisher","first-page":"1419808","DOI":"10.3389\/fonc.2024.1419808","volume":"14","author":"SS Blancas-Zugarazo","year":"2024","unstructured":"Blancas-Zugarazo SS, Langley E, Hidalgo-Miranda A. Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers. Front Oncol. 2024;14:1419808.","journal-title":"Front Oncol"},{"issue":"5","key":"2199_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41388-019-1040-y","volume":"39","author":"H Yousefi","year":"2020","unstructured":"Yousefi H, Maheronnaghsh M, Molaei F, Mashouri L, Reza Aref A, Momeny M, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39(5):953\u201374.","journal-title":"Oncogene"},{"issue":"1","key":"2199_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19\u201330.","journal-title":"Nat Cell Biol"},{"key":"2199_CR28","doi-asserted-by":"publisher","first-page":"1152672","DOI":"10.3389\/fphar.2023.1152672","volume":"14","author":"M Rezaee","year":"2023","unstructured":"Rezaee M, Mohammadi F, Keshavarzmotamed A, Yahyazadeh S, Vakili O, Milasi YE, et al. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. Front Pharmacol. 2023;14:1152672.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2199_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.clbc.2023.04.007","volume":"23","author":"J Chen","year":"2023","unstructured":"Chen J, Zhou Y, Wu M, Yuan Y, Wu W. m6A modification mediates exosomal LINC00657 to trigger breast cancer progression via inducing macrophage M2 polarization. Clin Breast Cancer. 2023;23(5):546\u201360.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"2199_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol cell Biol. 2018;19(3):143\u201357.","journal-title":"Nat Rev Mol cell Biol"},{"issue":"41","key":"2199_CR31","doi-asserted-by":"publisher","first-page":"14888","DOI":"10.1073\/pnas.1408301111","volume":"111","author":"JR Chevillet","year":"2014","unstructured":"Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci. 2014;111(41):14888\u201393.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"2199_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41419-024-07020-x","volume":"15","author":"Z Meng","year":"2024","unstructured":"Meng Z, Zhang R, Wu X, Piao Z, Zhang M, Jin T. LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p\/COL10A1 axis and exosome-mediated macrophage M2 polarization. Cell Death Dis. 2024;15(8):633.","journal-title":"Cell Death Dis"},{"key":"2199_CR33","doi-asserted-by":"publisher","first-page":"102076","DOI":"10.1016\/j.tranon.2024.102076","volume":"49","author":"X Wang","year":"2024","unstructured":"Wang X, Jian Q, Zhang Z, Gu J, Wang X, Wang Y. Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN\/Hippo\/YAP axis. Transl Oncol. 2024;49:102076.","journal-title":"Transl Oncol"},{"issue":"15","key":"2199_CR34","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.3390\/ijms23158351","volume":"23","author":"O Ashekyan","year":"2022","unstructured":"Ashekyan O, Abdallah S, Shoukari A, Al, Chamandi G, Choubassy H, Itani ARS, et al. Spotlight on exosomal non-coding RNAs in breast cancer: an in silico analysis to identify potential lncRNA\/circRNA-miRNA-target axis. Int J Mol Sci. 2022;23(15):8351.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2199_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12967-024-05771-x","volume":"22","author":"G Zhang","year":"2024","unstructured":"Zhang G, Cheng C, Wang X, Wang S. N 6-Methyladenosine methylation modification in breast cancer: current insights. J Transl Med. 2024;22(1):971.","journal-title":"J Transl Med"},{"issue":"1","key":"2199_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-025-03149-7","volume":"43","author":"L Wang","year":"2025","unstructured":"Wang L, Bai H, Li S, Li M, Hu Z, Xia Y. Radiotherapy affects the ELAVL1-mediated autophagy pathway by promoting the release of LINC01943 exosomes in breast cancer cells to accelerate the M2 polarization of macrophages. Med Oncol. 2025;43(1):13.","journal-title":"Med Oncol"},{"issue":"1","key":"2199_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","volume":"5","author":"C Ni","year":"2020","unstructured":"Ni C, Fang QQ, Chen WZ, Jiang JX, Jiang Z, Ye J, et al. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73\u2009+\u2009\u03b3\u03b41 Treg cells. Signal Transduct Target Ther. 2020;5(1):41.","journal-title":"Signal Transduct Target Ther"},{"key":"2199_CR38","doi-asserted-by":"publisher","first-page":"1593827","DOI":"10.3389\/fonc.2025.1593827","volume":"15","author":"ZW Wang","year":"2025","unstructured":"Wang ZW, Yang HS, Guo HS, Li YY, Zhong JY, Jiang S, et al. Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5. Front Oncol. 2025;15:1593827.","journal-title":"Front Oncol"},{"issue":"8","key":"2199_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12032-025-02836-9","volume":"42","author":"L Zheng","year":"2025","unstructured":"Zheng L, Mo J, He X, Xu Q, Bao Y, Wu J. lnc-MTRNR2L12-3 derived from hypoxic breast cancer cell exosomes facilitates angiogenesis via the Src\/FAK signaling pathway. Med Oncol. 2025;42(8):280.","journal-title":"Med Oncol"},{"key":"2199_CR40","doi-asserted-by":"publisher","first-page":"147230","DOI":"10.1016\/j.gene.2023.147230","volume":"860","author":"X Wei","year":"2023","unstructured":"Wei X, Tao S, Mao H, Zhu H, Mao L, Pei W, et al. Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b. Gene. 2023;860:147230.","journal-title":"Gene"},{"key":"2199_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.breast.2019.05.003","volume":"46","author":"YL Wang","year":"2019","unstructured":"Wang YL, Liu LC, Hung Y, Chen CJ, Lin YZ, Wu WR, et al. Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2\/HER2 positivity in breast cancer. Breast. 2019;46:64\u20139.","journal-title":"Breast"},{"issue":"2","key":"2199_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12038-019-9861-y","volume":"44","author":"S Tang","year":"2019","unstructured":"Tang S, Zheng K, Tang Y, Li Z, Zou T, Liu D. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients: S Tang et al. J Biosci. 2019;44(2):37.","journal-title":"J Biosci"},{"key":"2199_CR43","doi-asserted-by":"publisher","first-page":"115416","DOI":"10.1016\/j.intimp.2025.115416","volume":"165","author":"L Feng","year":"2025","unstructured":"Feng L, Wang Y, Wang X, Li B, Liu Y, Zhang W, et al. Exosomal lncRNA MIR210HG derived from hypoxic TAMs promotes the metastasis of triple negative breast cancer. Int Immunopharmacol. 2025;165:115416.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2199_CR44","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s10528-023-10531-5","volume":"62","author":"D Ma","year":"2024","unstructured":"Ma D, Wu J, Chen C, Niu Y, Ji K, Xiao Y, et al. M2 Macrophage-Derived exosomes regulate miR-199a-3p promoter methylation through the LINC00470-Mediated myc\/DNMT3a Axis to promote breast Cancer development. Biochem Genet. 2024;62(3):2082\u201399.","journal-title":"Biochem Genet"},{"key":"2199_CR45","doi-asserted-by":"crossref","unstructured":"Gao H, Hao G, Sun Y, Li L, Wang Y. Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process. Onco Targets Ther. 2018;8001\u201312.","DOI":"10.2147\/OTT.S172379"},{"key":"2199_CR46","doi-asserted-by":"publisher","first-page":"1384946","DOI":"10.3389\/fimmu.2024.1384946","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ma Q, Wang T, Xing J, Li Q, Wang D, et al. The involvement and application potential of exosomes in breast cancer immunotherapy. Front Immunol. 2024;15:1384946.","journal-title":"Front Immunol"},{"issue":"5867","key":"2199_CR47","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Sci (80-). 2008;319(5867):1244\u20137.","journal-title":"Sci (80-)"},{"issue":"23","key":"2199_CR48","doi-asserted-by":"publisher","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","volume":"285","author":"N Kosaka","year":"2010","unstructured":"Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285(23):17442\u201352.","journal-title":"J Biol Chem"},{"issue":"10","key":"2199_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020;19(10):673\u201394.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02199-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:02:44Z","timestamp":1785852164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02199-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02199-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the preparation of this manuscript, generative artificial intelligence tools were utilized exclusively to improve linguistic clarity and grammatical precision. All generated content was carefully reviewed, critically revised as needed, and formally approved by the authors, who retain full responsibility for the accuracy, integrity, and final version of the work.","order":2,"name":"Ethics","label":"Declaration on the Use of Generative AI in Scientific Writing","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"288"}}